Bronno van der Holt

Erasmus University Rotterdam

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Biology Cancer Biology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Mathijs van Schie

Delft University of Technology

NETHERLANDS

View details

Bas Groot Koerkamp

Erasmus University Rotterdam

NETHERLANDS

View details

Josée M. Zijlstra

NETHERLANDS

View details

S. Zweegman

NETHERLANDS

View details

Grigory Sidorenkov

University Medical Center Groningen

NETHERLANDS

View details

Pieternella J. Lugtenburg

University Medical Center

NETHERLANDS

View details

Otto S Hoekstra

Prof.

VU medisch centrum

NETHERLANDS

View details

Henrica de Vet

Professor of Clinimetrics

NETHERLANDS

View details

Niels W. C. J. van de Donk

NETHERLANDS

View details

Eivind Hovig

Professor/ Head, Center of Bioinformatics

University of Oslo

NORWAY

View details

Marten Poley

Erasmus University Rotterdam

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bronno van der Holt

Research Interests

Explore related searches

Contact this professor

Articles (10)

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial.

Allogeneic Stem Cell Transplantation in Patients >40 Years of Age With Acute Lymphoblastic Leukemia: Reduced Intensity Versus Myeloablative Conditioning.

Music to prevent deliriUm during neuroSurgerY (MUSYC): a single-centre, prospective randomised controlled trial.

Transarterial chemoembolization with drug-eluting beads vs. stereotactic body radiation therapy for hepatocellular carcinoma: Outcomes from a multicenter randomized phase II trial (The TRENDY trial): Short running title: TACE-DEB vs. SBRT for hepatocellular carcinoma.

Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile

Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features.

Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients

Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence.

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project.

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma

Collaborators (11)

Mathijs van Schie

Bas Groot Koerkamp

Josée M. Zijlstra

S. Zweegman

Grigory Sidorenkov

Pieternella J. Lugtenburg

Otto S Hoekstra

Henrica de Vet

Niels W. C. J. van de Donk

Eivind Hovig

Marten Poley

Make your next move.